Syon Capital LLC Sells 931 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Syon Capital LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,954 shares of the healthcare conglomerate’s stock after selling 931 shares during the period. Syon Capital LLC’s holdings in UnitedHealth Group were worth $6,553,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Western Pacific Wealth Management LP grew its holdings in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares during the period. MCF Advisors LLC grew its stake in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock worth $1,304,000 after purchasing an additional 20 shares during the period. Axiom Financial Strategies LLC boosted its stake in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after acquiring an additional 20 shares during the last quarter. Richwood Investment Advisors LLC raised its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after purchasing an additional 20 shares during the period. Finally, 44 Wealth Management LLC increased its position in shares of UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on UNH. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday. KeyCorp decreased their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research note on Monday. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $608.00.

UnitedHealth Group Price Performance

NYSE:UNH opened at $427.10 on Wednesday. The stock has a fifty day moving average of $508.83 and a 200 day moving average of $537.99. UnitedHealth Group Incorporated has a 52-week low of $417.12 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $390.67 billion, a price-to-earnings ratio of 27.55, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the firm earned $6.91 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.97%. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.